ArticlePharmaceutics2020

Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization Via Inhibition of VEGF Production.

Takuya Miyagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.